-
Ronald Sweren, MD
- Director, Phototherapy/Photopheresis Program, Department of Dermatology
- Assistant Professor of Dermatology
If you have been diagnosed with skin lymphoma, the Johns Hopkins Cutaneous Lymphoma Center is committed to providing you with the best available treatment for every stage of your condition. Our team of experts in dermatology, medical oncology, radiation oncology and transplant services are dedicated to help you manage your symptoms and maximize your quality of life.
Schedule An Appointment Schedule An Appointment
Schedule online through MyChart
Schedule by phone
Please note that only patients diagnosed with skin lymphoma should schedule appointments at our center. If you are not sure about your skin condition diagnosis or are concerned about a skin lesion that has not been diagnosed as lymphoma, please call 410-955-5933 to request an appointment at one of our general dermatology clinics.
What to Expect at Your Appointment
Consultation
Questionnaire
You may be asked to fill out a questionnaire that shows the impact of your skin lymphoma on different aspects of your life and well-being.
Testing
Imaging
For scans and x-rays, you may need another appointment. We will work with you and your schedule, particularly if you are traveling to Baltimore for care.
Meet the Experts
Refer a Patient
To refer a patient, please fax your patient’s pathology reports, contact information and a brief note to 410-502-2309. If you require quicker service or would like to speak directly with a physician, please call 410-955-5933.
We will triage the case and contact the patient directly. Following the procedure, we will fax a report of the case to the referring physician.
Locations for Care
Cutaneous Side Effects of Chemotherapies and Immunotherapies | What Providers Need to Know
Dermatologist Kevin Sharghi discusses cutaneous side effects of chemotherapies and immunotherapies. Sharghi explains how side effects from these therapies can be managed to improve the patient’s quality of life and prevent them from altering cancer treatment plans.